As Candel Therapeutics gears up for a planned U.S. approval push for its prostate cancer drug later this year, RTW ...

Former Voivod frontman Eric Forrest shares his stage three prostate cancer fight and vows: "I'm gonna beat this parasite!" ...

Let’s have the so-called “funeral” and move on. Is America great? If so, why are we rioting against the government? We are not dead yet, but we are in mourning.

RTW committed $100M in U.S. launch funding, subject to U.S. Food and Drug Administration (FDA) approval of aglatimagene ...

The Company is developing Teverelix® as a best-in-class market product for advanced prostate cancer patients with high CV ...

The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...

Researchers at Case Western Reserve University have discovered a way to breach one of cancer's most stubborn defenses: the impenetrable fortress that solid tumors build around themselves.

Sam Darnold and that stingy Seattle Seahawks defense captured the franchise's second Super Bowl championship on the familiar ...

A non-material loss before tax of US$5.3 million, includes US$26.7 million in non-cash finance costs associated with convertible bonds and increased asset amortization of US$11.9 million (2024: US$5.1 ...

At a per-patient level, 68 Ga-PSMA-11 identified 36% (18/50) of trial participants as having a positive scan, while 64 Cu-SAR-bisPSMA next-day imaging detected prostate cancer in 78% (39/50) of cases.

Glioblastoma patients, long shut out from immunotherapies that have transformed patient care in other cancers, could finally benefit from a new treatment option. Boston cancer researchers have found ...